Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial

被引：132
|
作者：
Kelley, John M. [1 ,2 ,3 ,4 ]
Kaptchuk, Ted J. [2 ,3 ]
Cusin, Cristina [3 ,4 ]
Lipkin, Samuel [3 ,4 ]
Fava, Maurizio [3 ,4 ]
机构：
[1] Endicott Coll, Dept Psychol, Beverly, MA 01915 USA
[2] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2012年 / 81卷 / 05期
关键词：
D O I：
10.1159/000337053
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [1] A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder
    Uchida, H
    Takeuchi, H
    Nomura, K
    Suzuki, T
    Watanabe, K
    Kashima, H
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A16 - A16
  • [2] RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION OF INTRANASAL OXYTOCIN FOR AUTISM SPECTRUM DISORDER
    Spanos, Marina
    Bethea, Terrence
    Alderman, Cheryl
    Johnson, Jacqueline
    Chandrasekhar, Tara
    Sikich, Linmarie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S162 - S162
  • [3] Escitalopram in the treatment of major depressive disorder: An open-label naturalistic trial in various settings
    Hranov, L.
    Staleva, I.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S92 - S93
  • [4] Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    David G Perahia
    Inmaculada Gilaberte
    Fujun Wang
    John G Watkin
    Michael J Detke
    [J]. BMC Psychiatry, 7
  • [5] Duloxetine in the treatment of major depressive disorder: an open-label study
    Hudson, James I.
    Perahia, David G.
    Gilaberte, Inmaculada
    Wang, Fujun
    Watkin, John G.
    Detke, Michael J.
    [J]. BMC PSYCHIATRY, 2007, 7 (1) : 43
  • [6] Open-label tiagabine monotherapy for major depressive disorder with anxiety
    Carpenter, LL
    Schecter, JM
    Tyrka, AR
    Mello, AF
    Mello, MF
    Haggarty, R
    Price, LH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 66 - 71
  • [7] MAJOR DEPRESSIVE DISORDER, ANHEDONIA, AND AGOMELATINE: AN OPEN-LABEL STUDY
    Martinotti, G.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Janiri, L.
    Di Giannantonio, M.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [8] MAJOR DEPRESSIVE DISORDER, ANHEDONIA AND AGOMELATINE: AN OPEN-LABEL STUDY
    di Giannantonio, M.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Conti, C. M.
    Acciavatti, T.
    Cornelio, M.
    Martinotti, G.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01): : 109 - 114
  • [9] An Open-Label, Pilot Study Evaluating the Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder
    Sadavoy, Joel
    Bain, Jerald
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (02) : 230 - 233
  • [10] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, Uri
    Carmeli, Gal
    Chalamish, Yossi
    Braw, Yoram
    Kirsch, Irving
    Shefet, Daphna
    Krieger, Israel
    Mendlovic, Shlomo
    Bloch, Yuval
    Lichtenberg, Pesach
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 707 - 710
12345